Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states

Background and Purpose GAT107 ((3aR,4S,9bS)‐4‐(4‐bromo‐phenyl)‐3a,4,5,9b‐tetrahydro‐3H‐cyclopenta‐[c]quinoline‐8‐sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2018-06, Vol.175 (11), p.1838-1854
Hauptverfasser: Papke, Roger L, Stokes, Clare, Damaj, M Imad, Thakur, Ganesh A, Manther, Khan, Treinin, Millet, Bagdas, Deniz, Kulkarni, Abhijit R, Horenstein, Nicole A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1854
container_issue 11
container_start_page 1838
container_title British journal of pharmacology
container_volume 175
creator Papke, Roger L
Stokes, Clare
Damaj, M Imad
Thakur, Ganesh A
Manther, Khan
Treinin, Millet
Bagdas, Deniz
Kulkarni, Abhijit R
Horenstein, Nicole A
description Background and Purpose GAT107 ((3aR,4S,9bS)‐4‐(4‐bromo‐phenyl)‐3a,4,5,9b‐tetrahydro‐3H‐cyclopenta‐[c]quinoline‐8‐sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel‐active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non‐conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. Experimental Approach Voltage‐clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. Key Results Long‐lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non‐conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR‐selective antagonist and in how effectively they promote current. Conclusions & Implications Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM‐inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non‐conducting states have common activity on signal transduction. Linked Articles This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc
doi_str_mv 10.1111/bph.13851
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5979752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047350658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3581-8a96323b80eb02458debab779df0a7b151f9d53dc5f395366d8aae5463dc950e3</originalsourceid><addsrcrecordid>eNp1kctOAyEUhonR2HpZ-AKGxJWLURjKwGxMtPGWmOhC14SBMxbTDhVom_pWvojPJFo1upAFEM53Pk7yI7RHyRHN67iZjo4ok5yuoT4diKrgTNJ11CeEiIJSKXtoK8YnQnJR8E3UK2W-MFn10fwOQnQxQZewNsnNdXK-w77Fb68Cd8745PKOT4cjHMDANPkQsY7RG6cTWLxwaYRj0s0YsOvszHz3W9e2ED68FiJ00SX3kvmMJog7aKPV4wi7X-c2erg4vx9eFTe3l9fD05vCMC5pIXVdsZI1kkBDygGXFhrdCFHblmjRUE7b2nJmDW9ZzVlVWak18EGVn2pOgG2jk5V3OmsmYE0eJ-ixmgY30WGpvHbqb6VzI_Xo54rXoha8zIKDL0HwzzOIST35WejyzKokA8E4qbjM1OGKMsHHGKD9-YES9RGRyhGpz4gyu_97pB_yO5MMHK-AhRvD8n-TOru7WinfAfupnxY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047350658</pqid></control><display><type>article</type><title>Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Papke, Roger L ; Stokes, Clare ; Damaj, M Imad ; Thakur, Ganesh A ; Manther, Khan ; Treinin, Millet ; Bagdas, Deniz ; Kulkarni, Abhijit R ; Horenstein, Nicole A</creator><creatorcontrib>Papke, Roger L ; Stokes, Clare ; Damaj, M Imad ; Thakur, Ganesh A ; Manther, Khan ; Treinin, Millet ; Bagdas, Deniz ; Kulkarni, Abhijit R ; Horenstein, Nicole A</creatorcontrib><description>Background and Purpose GAT107 ((3aR,4S,9bS)‐4‐(4‐bromo‐phenyl)‐3a,4,5,9b‐tetrahydro‐3H‐cyclopenta‐[c]quinoline‐8‐sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel‐active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non‐conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. Experimental Approach Voltage‐clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. Key Results Long‐lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non‐conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR‐selective antagonist and in how effectively they promote current. Conclusions &amp; Implications Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM‐inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non‐conducting states have common activity on signal transduction. Linked Articles This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.13851</identifier><identifier>PMID: 28477386</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Acetylcholine ; Acetylcholine receptors (nicotinic) ; Activation ; Allosteric properties ; Allosteric Regulation - drug effects ; alpha7 Nicotinic Acetylcholine Receptor - agonists ; alpha7 Nicotinic Acetylcholine Receptor - metabolism ; Animals ; Azabicyclo Compounds - pharmacology ; Desensitization ; Female ; Furans - pharmacology ; Inflammation ; Oocytes ; Pain ; Quinoline ; Quinolines - pharmacology ; Research Paper ; Sensitivity ; Signal transduction ; Sulfonamides ; Sulfonamides - pharmacology ; Themed Section: Research Papers ; Transduction ; Xenopus laevis</subject><ispartof>British journal of pharmacology, 2018-06, Vol.175 (11), p.1838-1854</ispartof><rights>2017 The British Pharmacological Society</rights><rights>2017 The British Pharmacological Society.</rights><rights>2018 The British Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3581-8a96323b80eb02458debab779df0a7b151f9d53dc5f395366d8aae5463dc950e3</citedby><cites>FETCH-LOGICAL-c3581-8a96323b80eb02458debab779df0a7b151f9d53dc5f395366d8aae5463dc950e3</cites><orcidid>0000-0002-2625-2850 ; 0000-0001-7505-1230 ; 0000-0002-4468-8658</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979752/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979752/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28477386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Papke, Roger L</creatorcontrib><creatorcontrib>Stokes, Clare</creatorcontrib><creatorcontrib>Damaj, M Imad</creatorcontrib><creatorcontrib>Thakur, Ganesh A</creatorcontrib><creatorcontrib>Manther, Khan</creatorcontrib><creatorcontrib>Treinin, Millet</creatorcontrib><creatorcontrib>Bagdas, Deniz</creatorcontrib><creatorcontrib>Kulkarni, Abhijit R</creatorcontrib><creatorcontrib>Horenstein, Nicole A</creatorcontrib><title>Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Background and Purpose GAT107 ((3aR,4S,9bS)‐4‐(4‐bromo‐phenyl)‐3a,4,5,9b‐tetrahydro‐3H‐cyclopenta‐[c]quinoline‐8‐sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel‐active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non‐conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. Experimental Approach Voltage‐clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. Key Results Long‐lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non‐conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR‐selective antagonist and in how effectively they promote current. Conclusions &amp; Implications Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM‐inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non‐conducting states have common activity on signal transduction. Linked Articles This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc</description><subject>Acetylcholine</subject><subject>Acetylcholine receptors (nicotinic)</subject><subject>Activation</subject><subject>Allosteric properties</subject><subject>Allosteric Regulation - drug effects</subject><subject>alpha7 Nicotinic Acetylcholine Receptor - agonists</subject><subject>alpha7 Nicotinic Acetylcholine Receptor - metabolism</subject><subject>Animals</subject><subject>Azabicyclo Compounds - pharmacology</subject><subject>Desensitization</subject><subject>Female</subject><subject>Furans - pharmacology</subject><subject>Inflammation</subject><subject>Oocytes</subject><subject>Pain</subject><subject>Quinoline</subject><subject>Quinolines - pharmacology</subject><subject>Research Paper</subject><subject>Sensitivity</subject><subject>Signal transduction</subject><subject>Sulfonamides</subject><subject>Sulfonamides - pharmacology</subject><subject>Themed Section: Research Papers</subject><subject>Transduction</subject><subject>Xenopus laevis</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOAyEUhonR2HpZ-AKGxJWLURjKwGxMtPGWmOhC14SBMxbTDhVom_pWvojPJFo1upAFEM53Pk7yI7RHyRHN67iZjo4ok5yuoT4diKrgTNJ11CeEiIJSKXtoK8YnQnJR8E3UK2W-MFn10fwOQnQxQZewNsnNdXK-w77Fb68Cd8745PKOT4cjHMDANPkQsY7RG6cTWLxwaYRj0s0YsOvszHz3W9e2ED68FiJ00SX3kvmMJog7aKPV4wi7X-c2erg4vx9eFTe3l9fD05vCMC5pIXVdsZI1kkBDygGXFhrdCFHblmjRUE7b2nJmDW9ZzVlVWak18EGVn2pOgG2jk5V3OmsmYE0eJ-ixmgY30WGpvHbqb6VzI_Xo54rXoha8zIKDL0HwzzOIST35WejyzKokA8E4qbjM1OGKMsHHGKD9-YES9RGRyhGpz4gyu_97pB_yO5MMHK-AhRvD8n-TOru7WinfAfupnxY</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Papke, Roger L</creator><creator>Stokes, Clare</creator><creator>Damaj, M Imad</creator><creator>Thakur, Ganesh A</creator><creator>Manther, Khan</creator><creator>Treinin, Millet</creator><creator>Bagdas, Deniz</creator><creator>Kulkarni, Abhijit R</creator><creator>Horenstein, Nicole A</creator><general>Blackwell Publishing Ltd</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2625-2850</orcidid><orcidid>https://orcid.org/0000-0001-7505-1230</orcidid><orcidid>https://orcid.org/0000-0002-4468-8658</orcidid></search><sort><creationdate>201806</creationdate><title>Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states</title><author>Papke, Roger L ; Stokes, Clare ; Damaj, M Imad ; Thakur, Ganesh A ; Manther, Khan ; Treinin, Millet ; Bagdas, Deniz ; Kulkarni, Abhijit R ; Horenstein, Nicole A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3581-8a96323b80eb02458debab779df0a7b151f9d53dc5f395366d8aae5463dc950e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acetylcholine</topic><topic>Acetylcholine receptors (nicotinic)</topic><topic>Activation</topic><topic>Allosteric properties</topic><topic>Allosteric Regulation - drug effects</topic><topic>alpha7 Nicotinic Acetylcholine Receptor - agonists</topic><topic>alpha7 Nicotinic Acetylcholine Receptor - metabolism</topic><topic>Animals</topic><topic>Azabicyclo Compounds - pharmacology</topic><topic>Desensitization</topic><topic>Female</topic><topic>Furans - pharmacology</topic><topic>Inflammation</topic><topic>Oocytes</topic><topic>Pain</topic><topic>Quinoline</topic><topic>Quinolines - pharmacology</topic><topic>Research Paper</topic><topic>Sensitivity</topic><topic>Signal transduction</topic><topic>Sulfonamides</topic><topic>Sulfonamides - pharmacology</topic><topic>Themed Section: Research Papers</topic><topic>Transduction</topic><topic>Xenopus laevis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papke, Roger L</creatorcontrib><creatorcontrib>Stokes, Clare</creatorcontrib><creatorcontrib>Damaj, M Imad</creatorcontrib><creatorcontrib>Thakur, Ganesh A</creatorcontrib><creatorcontrib>Manther, Khan</creatorcontrib><creatorcontrib>Treinin, Millet</creatorcontrib><creatorcontrib>Bagdas, Deniz</creatorcontrib><creatorcontrib>Kulkarni, Abhijit R</creatorcontrib><creatorcontrib>Horenstein, Nicole A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papke, Roger L</au><au>Stokes, Clare</au><au>Damaj, M Imad</au><au>Thakur, Ganesh A</au><au>Manther, Khan</au><au>Treinin, Millet</au><au>Bagdas, Deniz</au><au>Kulkarni, Abhijit R</au><au>Horenstein, Nicole A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2018-06</date><risdate>2018</risdate><volume>175</volume><issue>11</issue><spage>1838</spage><epage>1854</epage><pages>1838-1854</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Background and Purpose GAT107 ((3aR,4S,9bS)‐4‐(4‐bromo‐phenyl)‐3a,4,5,9b‐tetrahydro‐3H‐cyclopenta‐[c]quinoline‐8‐sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel‐active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non‐conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. Experimental Approach Voltage‐clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. Key Results Long‐lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non‐conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR‐selective antagonist and in how effectively they promote current. Conclusions &amp; Implications Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM‐inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non‐conducting states have common activity on signal transduction. Linked Articles This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28477386</pmid><doi>10.1111/bph.13851</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-2625-2850</orcidid><orcidid>https://orcid.org/0000-0001-7505-1230</orcidid><orcidid>https://orcid.org/0000-0002-4468-8658</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2018-06, Vol.175 (11), p.1838-1854
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5979752
source MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Acetylcholine
Acetylcholine receptors (nicotinic)
Activation
Allosteric properties
Allosteric Regulation - drug effects
alpha7 Nicotinic Acetylcholine Receptor - agonists
alpha7 Nicotinic Acetylcholine Receptor - metabolism
Animals
Azabicyclo Compounds - pharmacology
Desensitization
Female
Furans - pharmacology
Inflammation
Oocytes
Pain
Quinoline
Quinolines - pharmacology
Research Paper
Sensitivity
Signal transduction
Sulfonamides
Sulfonamides - pharmacology
Themed Section: Research Papers
Transduction
Xenopus laevis
title Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T11%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistent%20activation%20of%20%CE%B17%20nicotinic%20ACh%20receptors%20associated%20with%20stable%20induction%20of%20different%20desensitized%20states&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Papke,%20Roger%20L&rft.date=2018-06&rft.volume=175&rft.issue=11&rft.spage=1838&rft.epage=1854&rft.pages=1838-1854&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.13851&rft_dat=%3Cproquest_pubme%3E2047350658%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2047350658&rft_id=info:pmid/28477386&rfr_iscdi=true